Evidence map›Paper›PMID 29938775›Full record

ArticleThe British journal of dermatology2019

Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma.

E Tina, S Prosén, S Lennholm, G Gasparyan, M Lindberg, A Göthlin Eremo

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

E TinaClinical Research Laboratory, Faculty of Medicine and Health, Campus USÖ, Floor 3, Örebro University Hospital, SE-701 85, Örebro, Sweden.
S ProsénDepartment of Dermatology, Örebro University Hospital, Örebro, Sweden.
S LennholmSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
G GasparyanSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
M LindbergDepartment of Dermatology, Örebro University Hospital, Örebro, Sweden.
A Göthlin EremoClinical Research Laboratory, Faculty of Medicine and Health, Campus USÖ, Floor 3, Örebro University Hospital, SE-701 85, Örebro, Sweden.ORCID 0000-0002-7498-7157
Örebro University · SEÖrebro University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of basal cell carcinoma (BCC) is increasing and the costs for care rising. Therefore, the need for simplified and cost-effective treatment choices is substantial. Aberrant signalling in several pathways, induced by ultraviolet radiation, is of importance in the development of BCC. Alterations in tumour metabolic activity are part of general carcinogenesis; however, these alterations are only partially recognized in skin cancer.

objectivesTo study expression profiles in BCCs compared with individually matched nontumour skin, with a focus on finding differences associated with tumour metabolism. MATERIALS AND

methodsGene expression in biopsies from BCCs (n = 14) compared with biopsies from nontumour gluteal skin was analysed with microarrays (n = 4 + 4) and/or quantitative real-time polymerase chain reaction (qPCR, n = 14 + 14). Protein expression and localization was assessed using immunohistochemistry (IHC) in formalin-fixed and paraffin-embedded BCC samples.

resultsMicroarray analysis revealed increased expression of the amino acid transporters SLC7A5, SLC7A7 and SLC7A8 as well as the cytosolic enzyme tryptophan 2,3-dioxygenase (TDO) 2 in BCC. Higher expression of SLC7A5 (P < 0·001), SLC7A8 (P < 0·001) and TDO2 (P = 0·002), but not SLC7A7 (P = 0·50), was confirmed by qPCR, and IHC demonstrated correlating tumour cell protein expression of SLC7A5 and SLC7A8. Protein expression of SLC7A7 was observed in the stratum granulosum, and TDO2 in immune cells.

conclusionsThis study highlights the upregulation of SLC7A5, SLC7A8 and TDO2 in BCC compared with nontumour skin. Our findings imply that amino acid transporters may be further explored as potential targets for future medical treatment.

Indexed as

AgedAged, 80 and overAmino Acid Transport System y+Amino Acid Transport System y+LBasal Cell CarcinomaCohort StudiesFemaleFusion Regulatory Protein 1, Light ChainsHumansLarge Neutral Amino Acid-Transporter 1MaleMiddle AgedSkinSkin NeoplasmsTryptophan OxygenaseUp-RegulationAmino Acid Transport System y+Amino Acid Transport System y+LFusion Regulatory Protein 1, Light ChainsLarge Neutral Amino Acid-Transporter 1SLC7A7 protein, humanSLC7A8 protein, humanTryptophan Oxygenase

Identifiers

PMID29938775
PMCPMC7380045
OpenAlexW2810250539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.